(3-Carboxypropyl)trimethylammonium chloride
| Code | Size | Price |
|---|
| TAR-T4702-100mg | 100mg | £109.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
(3-Carboxypropyl)trimethylammonium chloride is a synthetic carnitine related compound used as a transporter substrate in the cloning and sequencing of human carnitine transporter 2 (CT2).
CAS:
6249-56-5
Formula:
C7H16ClNO2
Molecular Weight:
181.66
Pathway:
Metabolism
Purity:
0.9967
SMILES:
[Cl-].C[N+](C)(C)CCCC(O)=O
Target:
Endogenous Metabolite
References
Koeth RA, et al. ?-Butyrobetaine is a proatherogenic intermediate in gut microbial metabolism of L-carnitine to TMAO. Cell Metab. 2014 Nov 4;20(5):799-812.
Susumu Ogawa, et al. The Dynamics of Carnitine, ?-butyrobetaine and Trimethylamine N-oxide in Diabetics and the Effects of Changes in Renal Function. Ogawa et al., J Nephrol Ren Dis 2017, 1:2